|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
|
|---|---|---|---|---|---|
| Revenues: | |||||
| Premium | |||||
| Products and services | |||||
| Investment and other income | |||||
| Total revenues | |||||
| Expenses and other: | |||||
| Medical benefits | |||||
| Costs of products and services | |||||
| Selling, general and administrative | |||||
| ACA industry fee | |||||
| Medicaid premium taxes | |||||
| Depreciation and amortization | |||||
| Interest | |||||
| Impairment and other charges | |||||
| Gain on divestiture of business | |||||
| Total expenses, net | |||||
| Income from operations | |||||
| Bargain purchase gain | |||||
| Loss on extinguishment of debt | |||||
| Loss before income taxes | |||||
| Equity in (losses) earnings of unconsolidated subsidiaries | |||||
| Income before income taxes | |||||
| Income tax expense | |||||
| Net income | |||||
| Other comprehensive income, before tax: | |||||
| Change in net unrealized gains and losses on available-for-sale securities | |||||
| Income tax (benefit) expense related to other comprehensive (loss) income | |||||
| Other comprehensive (loss) income, net of tax | |||||
| Comprehensive income | |||||
| Earnings per common share (see Note 5): | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...
